Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Old Ayala, Inc (AYLA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/08/2023 |
SC 13G/A
| Redmile Group, LLC reports a 0% stake in OLD AYALA, Inc. |
| 02/07/2023 |
SC 13G
| Harel Insurance Investments & Financial Services Ltd. reports a 8.3% stake in Ayala Pharmaceuticals, Inc. |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/30/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 01/25/2023 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 01/24/2023 |
4
| aMoon Growth Fund Limited Partnership (10% Owner) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 2,991,473 shares
@ $0 |
|
| 01/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/23/2023 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 250 shares
@ $0
Disposed/sold 12,500 options to buy
@ $10.35, valued at
$129.4k
Disposed/sold 12,500 options to buy
@ $1.63, valued at
$20.4k
|
|
| 01/23/2023 |
4
| Maimon Yossi (CFO, Secretary and Treasurer) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 69,872 shares
@ $0
Disposed/sold 70,500 options to buy
@ $5.16, valued at
$363.8k
Disposed/sold 9,460 options to buy
@ $6.5, valued at
$61.5k
Disposed/sold 19,170 options to buy
@ $11.26, valued at
$215.9k
Disposed/sold 31,950 options to buy
@ $9.105, valued at
$290.9k
|
|
| 01/23/2023 |
4
| Spiegel Robert J. (Director) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 17,500 options to buy
@ $5.1, valued at
$89.3k
Disposed/sold 12,500 options to buy
@ $8.84, valued at
$110.5k
Disposed/sold 6,250 options to buy
@ $10.35, valued at
$64.7k
Disposed/sold 6,250 options to buy
@ $1.63, valued at
$10.2k
|
|
| 01/23/2023 |
4
| Gordon Gary B. (Chief Medical Officer) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 58,520 shares
@ $0
Disposed/sold 89,000 options to buy
@ $5.16, valued at
$459.2k
Disposed/sold 19,170 options to buy
@ $11.26, valued at
$215.9k
Disposed/sold 31,950 options to buy
@ $9.105, valued at
$290.9k
|
|
| 01/23/2023 |
4
| GOLDBERG MURRAY A (Director) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 17,500 options to buy
@ $5.1, valued at
$89.3k
Disposed/sold 12,500 options to buy
@ $8.84, valued at
$110.5k
Disposed/sold 6,250 options to buy
@ $10.35, valued at
$64.7k
Disposed/sold 6,250 options to buy
@ $1.63, valued at
$10.2k
|
|
| 01/23/2023 |
4
| Bisker-Leib Vered (Director) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 8,750 options to buy
@ $10.98, valued at
$96.1k
Disposed/sold 6,250 options to buy
@ $10.35, valued at
$64.7k
Disposed/sold 6,250 options to buy
@ $1.63, valued at
$10.2k
|
|
| 01/23/2023 |
4
| Mamluk Roni (President & CEO) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 265,345 shares
@ $0
Disposed/sold 47,299 options to buy
@ $15, valued at
$709.5k
Disposed/sold 76,680 options to buy
@ $11.26, valued at
$863.4k
Disposed/sold 127,800 options to buy
@ $9.105, valued at
$1.2M
|
|
| 01/23/2023 |
SC 13G/A
| Schindel Yair Chaim reports a 0% stake in Ayala Pharmaceutics, Inc |
| 01/19/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/19/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/19/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/19/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 01/13/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 01/09/2023 |
SC 13G/A
| Schindel Yair Chaim reports a 20.2% stake in Ayala Pharmaceutics, Inc |
| 01/04/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/04/2023 |
8-K
| Other Events Interactive Data |
| 12/12/2022 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 11/23/2022 |
8-K
| Quarterly results |
| 11/17/2022 |
8-K
| Quarterly results |
| 11/04/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/31/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/19/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/19/2022 |
8-K
| Quarterly results |
| 09/12/2022 |
8-K
| Other Events Interactive Data |
|
|
|